High levels of catalytic antibodies correlate with favorable outcome in sepsis
Authors:
- Sébastien Lacroix‐DesmazesSLSébastien Lacroix‐Desmazes
- Jagadeesh BayryJagadeesh Bayry
- Srini V. KaveriSKSrini V. Kaveri
- David Hayon-SonsinoDHDavid Hayon-Sonsino
- Nithyananda ThorenoorNithyananda Thorenoor
- Julien CharpentierJCJulien Charpentier
- Charles-Edouard LuytCLCharles-Edouard Luyt
- Jean-Paul MiraJMJean-Paul Mira
- Valakunja NagarajaVNValakunja Nagaraja
- Michel D. KazatchkineMKMichel D. Kazatchkine
- Jean-François DhainautJDJean-François Dhainaut
- Vincent MalletVMVincent Mallet
Open Access
- 2 March 2005
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 102 (11) , 4109-4113
Abstract
Sepsis is the leading cause of death in intensive care units and results from a deleterious systemic host response to infection. Although initially perceived as potentially deleterious, catalytic antibodies have been proposed to participate in removal of metabolic wastes and protection against infection. Here we show that the presence in plasma of IgG endowed with serine protease-like hydrolytic activity strongly correlates with survival from sepsis. Variances of catalytic rates of IgG were greater in the case of patients with severe sepsis than healthy donors (P < 0.001), indicating that sepsis is associated with alterations in plasma levels of hydrolytic IgG. The catalytic rates of IgG from patients who survived were significantly greater than those of IgG from deceased patients (P < 0.05). The cumulative rate of survival was higher among patients exhibiting high rates of IgG-mediated hydrolysis as compared with patients with low hydrolytic rates (P < 0.05). An inverse correlation was also observed between the markers of severity of disseminated intravascular coagulation and rates of hydrolysis of patients' IgG. Furthermore, IgG from three surviving patients hydrolyzed factor VIII, one of which also hydrolyzed factor IX, suggesting that, in some patients, catalytic IgG may participate in the control of disseminated microvascular thrombosis. Our observations provide the first evidence that hydrolytic antibodies might play a role in recovery from a disease.Keywords
This publication has 35 references indexed in Scilit:
- Drotrecogin alfa (activated) (recombinant human activated protein C) reduces host coagulopathy response in patients with severe sepsisThrombosis and Haemostasis, 2003
- Evidence for Antibody-Catalyzed Ozone Formation in Bacterial Killing and InflammationScience, 2002
- Catalytic Antibody Bridges Innate and Adaptive ImmunityScience, 2002
- Invasive Aspergillosis in 2002: An UpdateEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- The Prevalence of Proteolytic Antibodies against Factor VIII in Hemophilia ANew England Journal of Medicine, 2002
- Catalytic heterogeneity of polyclonal DNA-hydrolyzing antibodies from the sera of patients with multiple sclerosisImmunology Letters, 2001
- Monoclonal Antibody Light Chain with Prothrombinase ActivityBiochemistry, 2000
- Phosphorylation of different human milk proteins by human catalytic secretory immunoglobulin AIUBMB Life, 1996
- DNA‐specific antiidiotypic antibodies in the sera of patients with autoimmune diseasesFEBS Letters, 1992
- DNA Hydrolyzing AutoantibodiesScience, 1992